Brigatinib is a small molecule which can act as a pan-ALK inhibitor. It is provided as a powder.
This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: EGF.
This product may be of interest in the following research areas and diseases: Cancer.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.